Want to see IN:IPCALAB full AI Analyst Report?
IPCA Laboratories Limited (IPCALAB) Ratios
IPCA Laboratories Limited Ratios
IN:IPCALAB's free cash flow for Q4 2026 was $0.00. For the 2026 fiscal year, IN:IPCALAB's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.76 | 2.50 | 2.35 | 2.87 | 3.04 |
| Quick Ratio | 1.58 | 1.43 | 1.30 | 1.91 | 1.77 |
| Cash Ratio | 0.24 | 0.07 | 0.09 | 0.70 | 0.19 |
| Solvency Ratio | 0.55 | 0.33 | 0.26 | 0.26 | 0.53 |
| Operating Cash Flow Ratio | 0.50 | 0.53 | 0.40 | 0.45 | 0.58 |
| Short-Term Operating Cash Flow Coverage | 1.92 | 1.68 | 1.17 | 1.00 | 2.16 |
| Net Current Asset Value | $ 35.27B | $ 25.95B | $ 21.65B | $ 24.78B | $ 23.75B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.12 | 0.13 | 0.17 | 0.11 |
| Debt-to-Equity Ratio | 0.10 | 0.20 | 0.23 | 0.25 | 0.15 |
| Debt-to-Capital Ratio | 0.09 | 0.16 | 0.19 | 0.20 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.07 | 0.08 | 0.10 | 0.07 |
| Financial Leverage Ratio | 1.53 | 1.69 | 1.75 | 1.48 | 1.39 |
| Debt Service Coverage Ratio | 2.35 | 1.56 | 1.01 | 0.81 | 2.58 |
| Interest Coverage Ratio | 30.70 | 41.74 | 22.77 | 49.45 | 224.50 |
| Debt to Market Cap | 0.02 | 0.04 | 0.04 | 0.07 | 0.03 |
| Interest Debt Per Share | 34.88 | 57.18 | 61.82 | 60.19 | 32.22 |
| Net Debt to EBITDA | 0.12 | 0.72 | 0.97 | 0.24 | 0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.10% | 65.54% | 63.05% | 59.62% | 62.13% |
| EBIT Margin | 16.00% | 14.51% | 12.09% | 11.26% | 18.16% |
| EBITDA Margin | 20.33% | 18.64% | 16.41% | 15.14% | 21.87% |
| Operating Profit Margin | 24.17% | 41.00% | 38.42% | 36.26% | 39.27% |
| Pretax Profit Margin | 16.25% | 12.63% | 10.85% | 11.72% | 19.12% |
| Net Profit Margin | 11.83% | 8.25% | 7.10% | 7.54% | 15.16% |
| Continuous Operations Profit Margin | 12.27% | 8.78% | 6.79% | 7.67% | 15.26% |
| Net Income Per EBT | 72.78% | 65.35% | 65.44% | 64.36% | 79.32% |
| EBT Per EBIT | 67.25% | 30.79% | 28.25% | 32.33% | 48.67% |
| Return on Assets (ROA) | 9.22% | 6.27% | 4.93% | 5.46% | 11.60% |
| Return on Equity (ROE) | 14.15% | 10.62% | 8.64% | 8.07% | 16.10% |
| Return on Capital Employed (ROCE) | 23.17% | 39.11% | 33.86% | 33.22% | 37.19% |
| Return on Invested Capital (ROIC) | 16.49% | 25.14% | 19.36% | 19.41% | 27.88% |
| Return on Tangible Assets | 9.37% | 6.38% | 5.04% | 5.59% | 11.92% |
| Earnings Yield | 2.81% | 2.09% | 1.74% | 2.29% | 3.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.67 | 4.67 | 4.55 | 6.27 | 6.35 |
| Payables Turnover | 3.68 | 3.64 | 3.67 | 4.81 | 3.96 |
| Inventory Turnover | 1.27 | 1.20 | 1.15 | 1.45 | 1.19 |
| Fixed Asset Turnover | 1.85 | 1.91 | 1.64 | 2.32 | 2.33 |
| Asset Turnover | 0.78 | 0.76 | 0.69 | 0.72 | 0.76 |
| Working Capital Turnover Ratio | 2.52 | 2.64 | 2.35 | 1.96 | 2.21 |
| Cash Conversion Cycle | 266.84 | 281.29 | 297.34 | 234.45 | 272.42 |
| Days of Sales Outstanding | 78.10 | 78.24 | 80.27 | 58.19 | 57.47 |
| Days of Inventory Outstanding | 287.85 | 303.28 | 316.56 | 252.22 | 307.14 |
| Days of Payables Outstanding | 99.11 | 100.23 | 99.48 | 75.96 | 92.19 |
| Operating Cycle | 365.95 | 381.52 | 396.83 | 310.41 | 364.61 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 45.02 | 50.26 | 37.23 | 31.76 | 33.74 |
| Free Cash Flow Per Share | 19.16 | 19.69 | 21.02 | 12.27 | 14.86 |
| Dividend Paid and CapEx Coverage Ratio | 1.61 | 1.45 | 2.04 | 1.35 | 1.47 |
| Capital Expenditure Coverage Ratio | 1.74 | 1.64 | 2.30 | 1.63 | 1.79 |
| Operating Cash Flow Coverage Ratio | 1.41 | 0.94 | 0.66 | 0.54 | 1.06 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.14 | 0.12 | 0.13 | 0.15 |
| Free Cash Flow Yield | 1.20% | 1.42% | 1.69% | 1.51% | 1.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 35.60 | 47.83 | 57.52 | 43.62 | 30.58 |
| Price-to-Sales (P/S) Ratio | 4.21 | 3.95 | 4.09 | 3.29 | 4.64 |
| Price-to-Book (P/B) Ratio | 5.04 | 5.08 | 4.97 | 3.52 | 4.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 83.57 | 70.64 | 59.03 | 66.03 | 71.70 |
| Price-to-Operating Cash Flow Ratio | 35.57 | 27.67 | 33.33 | 25.51 | 31.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.65 | 1.37 | 3.57 | -0.93 | -1.35 |
| Enterprise Value Multiple | 20.83 | 21.89 | 25.87 | 21.97 | 21.63 |
| Enterprise Value | 408.61B | 364.82B | 327.15B | 207.82B | 275.71B |
| EV to EBITDA | 20.83 | 21.89 | 25.87 | 21.97 | 21.63 |
| EV to Sales | 4.24 | 4.08 | 4.25 | 3.33 | 4.73 |
| EV to Free Cash Flow | 84.07 | 73.03 | 61.34 | 66.75 | 73.11 |
| EV to Operating Cash Flow | 35.78 | 28.61 | 34.63 | 25.79 | 32.21 |
| Tangible Book Value Per Share | 367.67 | 322.62 | 295.38 | 225.38 | 210.31 |
| Shareholders’ Equity Per Share | 317.89 | 273.88 | 249.59 | 230.27 | 216.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.30 | 0.37 | 0.35 | 0.20 |
| Revenue Per Share | 380.28 | 352.43 | 303.74 | 246.28 | 229.82 |
| Net Income Per Share | 44.99 | 29.08 | 21.57 | 18.58 | 34.85 |
| Tax Burden | 0.73 | 0.65 | 0.65 | 0.64 | 0.79 |
| Interest Burden | 1.02 | 0.87 | 0.90 | 1.04 | 1.05 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.12 | 0.22 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.73 | 1.73 | 1.73 | 1.08 | 0.75 |
Currency in INR